Pura Vida Investments’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Pura Vida Investments’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-70,000	Closed	-$2.09M	–	112
2017 Q2	$2.09M	Sell	70,000 -33,850	-33%	-$877K	0.83%	39
2017 Q1	$2.76M	Buy	103,850 +23,667	+30%	+$586K	0.82%	50
2016 Q4	$1.78M	Buy	80,183 +40,000	+100%	+$748K	0.65%	45
2016 Q3	$743K	Buy	40,183 +15,500	+63%	+$269K	0.23%	76
2016 Q2	$401K	Buy	+24,683	New	+$416K	0.17%	69
2015 Q3	–	Sell	-53,000	Closed	-$1.01M	–	84
2015 Q2	$1.01M	Buy	+53,000	New	+$746K	0.51%	56

Other funds holding NDRM

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

CFIC

City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

Pura Vida Investments's NDRM Position: Q3 2017 in Review

Pura Vida Investments sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2017, closing a stake of 70,000 shares — an estimated $2.09M sold.

Pura Vida Investments first reported a position in NDRM in Q2 2015 and held it in 6 quarters. The position peaked at $2.76M in Q1 2017. 81 funds tracked by Wall St. Rank hold NDRM as of Q3 2017.

Pura Vida Investments reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Pura Vida Investments sold 70,000 NeuroDerm Ltd. Ordinary Shares shares in Q3 2017, an estimated $2.09M.
Pura Vida Investments first reported a position in NeuroDerm Ltd. Ordinary Shares in Q2 2015 and held it in 6 quarters.
Pura Vida Investments's NeuroDerm Ltd. Ordinary Shares position peaked at $2.76M in Q1 2017.
81 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2017.

Based on Pura Vida Investments's 13F filing for Q3 2017, filed 14 Nov 2017.